Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 4, 2006, Pages 1155-1160

  Buchholz, Thomas A ^a   Strom, Eric A ^a   Oswald, Mary Jane ^a   Perkins, George H ^a   Oh, Julia ^a   Domain, Delora ^a   Yu, Tse Kuan ^a   Woodward, Wendy A ^a   Tereffe, Welela ^a   Singletary, S Eva ^a   Thomas, Eva ^a   Buzdar, Aman U ^a   Hortobagyi, Gabriel N ^a   McNeese, Marsha D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Chemotherapy; Clinical trial; Hyperfractionated radiotherapy

Indexed keywords

BREAST CANCER; CHEST WALL IRRADIATION; CLINICAL TRIAL; HYPERFRACTIONATED RADIOTHERAPY;

CHEMOTHERAPY; ONCOLOGY; PATIENT MONITORING; TUMORS;

RADIOTHERAPY;

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FOLINATE CALCIUM; METHOTREXATE; PREDNISONE; VINBLASTINE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DISEASE SEVERITY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MASTITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THORAX WALL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE;

EID: 33745185114     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.02.026     Document Type: Article

References (11)

1. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337 (1997) 949-955
2. Overgaard M., Jensen M.-J., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen. Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet 353 (1999) 1641-1648
3. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy. 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126
4. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival. An overview of the randomised trials. Lancet 366 (2006) 2087-2106
5. Huang E.H., Tucker S.L., Strom E.A., et al. Predictors of local-regional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiation. Int J Radiat Oncol Biol Phys 62 (2005) 351-357
6. Thomas E., Holmes F.A., Smith T.L., et al. The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer. long-term results from a prospective randomized trial. J Clin Oncol 22 (2004) 2294-2302
7. Cox J.D., Pajak T.F., Herkscovic A., et al. Five-year survival after hyperfractionated radiation therapy for non-small-cell carcinoma of the lung (NSCCL). Results of RTOG protocol 81-08. Am J Clin Oncol 14 (1999) 280-284
8. Fu K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head-and-neck squamous cell carcinomas. First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
9. Liao Z., Strom E.A., Buzdar A.U., et al. Locoregional irradiation for inflammatory breast cancer. Effectiveness of dose escalation in decreasing recurrence. Int J Radiat Oncol Biol Phys 47 (2000) 1191-1200
10. Ballo M.T., Strom E.A., Prost H., et al. Locoregional control of recurrent breast carcinoma after mastectomy. Does hyperfractionated, accelerated radiotherapy improve local control?. Int J Radiat Oncol Biol Phys 44 (1999) 105-112
11. Woodward W.A., Strom E.A., Tucker S.L., et al. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy radiation. Implications for patients with early-stage disease and predictors for recurrence after radiation. Int J Radiat Oncol Biol Phys 57 (2003) 336-344